Gut Imaging for Function & Transit in Cystic Fibrosis Study 2

NCT04006873 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Tezacaftor/Ivacaftor + Ivacaftor
DRUG: Placebo oral tablet

Sponsor

Nottingham University Hospitals NHS Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]